TVM Capital Life Science

📍 Munich - Germany, Germany🗓 Founded 1983👥 43 employees
Venture Capital and Private Equity Principals🌐 tvm-capital.com
Website LinkedIn
TVM is a leading international venture capital firm focused on investing in life science innovations. The company has a highly experienced transatlantic investment team and approximately $900 million under management. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages the firm’s strategic relationship with global pharmaceutical firm, Eli Lilly and Company. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics. The TVM investment team has worked together for over a decade to effectively utilize this innovative approach to maximize returns for investors and finance new therapies and technologies to meaningfully improve patient lives.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
1983
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was TVM Capital Life Science founded?
TVM Capital Life Science was founded in 1983.
What industry is TVM Capital Life Science in?
TVM Capital Life Science operates in Venture Capital and Private Equity Principals. Find similar Venture Capital and Private Equity Principals investors on gritt.io.
Where is TVM Capital Life Science based?
TVM Capital Life Science is headquartered in Munich - Germany, Germany.